Review



primary antibodies: cd63, cd81, tsg101, calnexin, pi3k, p-pi3k, akt, p-akt, β-actin  (Abmart Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Abmart Inc primary antibodies: cd63, cd81, tsg101, calnexin, pi3k, p-pi3k, akt, p-akt, β-actin
    Primary Antibodies: Cd63, Cd81, Tsg101, Calnexin, Pi3k, P Pi3k, Akt, P Akt, β Actin, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pmc12271427-93-21-26?v=Abmart+Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies: cd63, cd81, tsg101, calnexin, pi3k, p-pi3k, akt, p-akt, β-actin - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    86
    System Biosciences Inc primary anti cd81 antibody
    Primary Anti Cd81 Antibody, supplied by System Biosciences Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pm41931140-65-13-24?v=System+Biosciences+Inc
    Average 86 stars, based on 1 article reviews
    primary anti cd81 antibody - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc cd81 primary antibodies
    Preparation of mouse BMSCs and their exosomes. (A) Morphological observation of mouse BMSCs at 120× magnification. To ensure objectivity, five random fields were selected for observation in each analysis. (B) Flow cytometry analysis of the expression of surface markers CD105, CD90, CD73 and CD34 in passage 2 BMSCs. (C) SEM characterization of BMSCs‐Exos. (D) Particle size analysis of BMSCs‐Exos using NTA. (E) Western blot analysis of CD9, CD63, and <t>CD81</t> protein expression in BMSCs‐Exos, with lysis buffer used as a negative control. Three biological replicates were performed for the experiment ( n = 3), and each replicate was tested three times.
    Cd81 Primary Antibodies, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pmc12704038-71-5-12?v=Cell+Signaling+Technology+Inc
    Average 86 stars, based on 1 article reviews
    cd81 primary antibodies - by Bioz Stars, 2026-07
    86/100 stars
      Buy from Supplier

    90
    Boster Bio cd81 primary antibody
    Differential analysis of CD8 + T cells between untreated and GCP-treated ICC samples. (A) UMAP plots showing all T cells labeled in different colors according to cell type annotation. (B) Volcano plot showing the differentially expressed genes of intra-tumoral CD8 + T cells between pretreated and posttreated ICC samples. (C) Immunofluorescence images showing the infiltration of CD8 + <t>CD81</t> + T cells in treatment-naïve ICC samples from the TMA cohort (n=89). Kaplan–Meier survival curves for OS (D) and RFS (E) of 89 ICC patients grouped by infiltration levels of CD8 + CD81 + T cells. P values were determined via log-rank test. (F) Boxplot showing infiltration levels of CD8 + CD81 + T cells in GCP-treated tumors revealed by multiplex immunofluorescence in GCP cohort. (G) Violin plots showing the expression scores of tissue resident, exhausted, and co-stimulatory gene signatures in tumor-infiltrating CD8 + T cells between pretreated and posttreated samples. The P values were calculated by Wilcox test. OS, overall survival; RFS, recurrence-free survival. ****p < 0.0001.
    Cd81 Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pmc12706460-72-7-13?v=Boster+Bio
    Average 90 stars, based on 1 article reviews
    cd81 primary antibody - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    96
    Proteintech anti cd81 primary antibody
    Differential analysis of CD8 + T cells between untreated and GCP-treated ICC samples. (A) UMAP plots showing all T cells labeled in different colors according to cell type annotation. (B) Volcano plot showing the differentially expressed genes of intra-tumoral CD8 + T cells between pretreated and posttreated ICC samples. (C) Immunofluorescence images showing the infiltration of CD8 + <t>CD81</t> + T cells in treatment-naïve ICC samples from the TMA cohort (n=89). Kaplan–Meier survival curves for OS (D) and RFS (E) of 89 ICC patients grouped by infiltration levels of CD8 + CD81 + T cells. P values were determined via log-rank test. (F) Boxplot showing infiltration levels of CD8 + CD81 + T cells in GCP-treated tumors revealed by multiplex immunofluorescence in GCP cohort. (G) Violin plots showing the expression scores of tissue resident, exhausted, and co-stimulatory gene signatures in tumor-infiltrating CD8 + T cells between pretreated and posttreated samples. The P values were calculated by Wilcox test. OS, overall survival; RFS, recurrence-free survival. ****p < 0.0001.
    Anti Cd81 Primary Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pmc12605549-43-29-32?v=Proteintech
    Average 96 stars, based on 1 article reviews
    anti cd81 primary antibody - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    94
    Novus Biologicals primary 179 antibodies
    Differential analysis of CD8 + T cells between untreated and GCP-treated ICC samples. (A) UMAP plots showing all T cells labeled in different colors according to cell type annotation. (B) Volcano plot showing the differentially expressed genes of intra-tumoral CD8 + T cells between pretreated and posttreated ICC samples. (C) Immunofluorescence images showing the infiltration of CD8 + <t>CD81</t> + T cells in treatment-naïve ICC samples from the TMA cohort (n=89). Kaplan–Meier survival curves for OS (D) and RFS (E) of 89 ICC patients grouped by infiltration levels of CD8 + CD81 + T cells. P values were determined via log-rank test. (F) Boxplot showing infiltration levels of CD8 + CD81 + T cells in GCP-treated tumors revealed by multiplex immunofluorescence in GCP cohort. (G) Violin plots showing the expression scores of tissue resident, exhausted, and co-stimulatory gene signatures in tumor-infiltrating CD8 + T cells between pretreated and posttreated samples. The P values were calculated by Wilcox test. OS, overall survival; RFS, recurrence-free survival. ****p < 0.0001.
    Primary 179 Antibodies, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pm41077099-83-0-9?v=Novus+Biologicals
    Average 94 stars, based on 1 article reviews
    primary 179 antibodies - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    96
    Proteintech primary anti cd81
    Differential analysis of CD8 + T cells between untreated and GCP-treated ICC samples. (A) UMAP plots showing all T cells labeled in different colors according to cell type annotation. (B) Volcano plot showing the differentially expressed genes of intra-tumoral CD8 + T cells between pretreated and posttreated ICC samples. (C) Immunofluorescence images showing the infiltration of CD8 + <t>CD81</t> + T cells in treatment-naïve ICC samples from the TMA cohort (n=89). Kaplan–Meier survival curves for OS (D) and RFS (E) of 89 ICC patients grouped by infiltration levels of CD8 + CD81 + T cells. P values were determined via log-rank test. (F) Boxplot showing infiltration levels of CD8 + CD81 + T cells in GCP-treated tumors revealed by multiplex immunofluorescence in GCP cohort. (G) Violin plots showing the expression scores of tissue resident, exhausted, and co-stimulatory gene signatures in tumor-infiltrating CD8 + T cells between pretreated and posttreated samples. The P values were calculated by Wilcox test. OS, overall survival; RFS, recurrence-free survival. ****p < 0.0001.
    Primary Anti Cd81, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pmc12487277-144-18-27?v=Proteintech
    Average 96 stars, based on 1 article reviews
    primary anti cd81 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    90
    Abmart Inc primary antibodies: cd63, cd81, tsg101, calnexin, pi3k, p-pi3k, akt, p-akt, β-actin
    Differential analysis of CD8 + T cells between untreated and GCP-treated ICC samples. (A) UMAP plots showing all T cells labeled in different colors according to cell type annotation. (B) Volcano plot showing the differentially expressed genes of intra-tumoral CD8 + T cells between pretreated and posttreated ICC samples. (C) Immunofluorescence images showing the infiltration of CD8 + <t>CD81</t> + T cells in treatment-naïve ICC samples from the TMA cohort (n=89). Kaplan–Meier survival curves for OS (D) and RFS (E) of 89 ICC patients grouped by infiltration levels of CD8 + CD81 + T cells. P values were determined via log-rank test. (F) Boxplot showing infiltration levels of CD8 + CD81 + T cells in GCP-treated tumors revealed by multiplex immunofluorescence in GCP cohort. (G) Violin plots showing the expression scores of tissue resident, exhausted, and co-stimulatory gene signatures in tumor-infiltrating CD8 + T cells between pretreated and posttreated samples. The P values were calculated by Wilcox test. OS, overall survival; RFS, recurrence-free survival. ****p < 0.0001.
    Primary Antibodies: Cd63, Cd81, Tsg101, Calnexin, Pi3k, P Pi3k, Akt, P Akt, β Actin, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pmc12271427-93-21-26?v=Abmart+Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies: cd63, cd81, tsg101, calnexin, pi3k, p-pi3k, akt, p-akt, β-actin - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    96
    Proteintech primary antibodies against cd81
    Characterization of UCMSCs and UCMSC-EVs. ( A ) Phase-contrast image of UCMSCs cultured on the plastic culture plate. Scale bar: 100 μm. ( B ) Representative histograms showing the expression of CD105, CD90, CD73, CD45, CD34, and HLA-DR on the surface of UCMSCs. Unstained cells were included as negative controls to validate the specificity of antibody staining. ( C ) Flow cytometry analysis to quantify the percentage of UCMSC-EVs positive for CD9, CD63, and <t>CD81.</t> ( D ) Western blot analysis of the protein expressions of CD63, CD81, and α-tubulin in UCMSCs and UCMSC-EVs. ( E ) Morphology of UCMSC-EVs (arrowhead), as observed using TEM.
    Primary Antibodies Against Cd81, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pmc12386668-191-8-12?v=Proteintech
    Average 96 stars, based on 1 article reviews
    primary antibodies against cd81 - by Bioz Stars, 2026-07
    96/100 stars
      Buy from Supplier

    90
    Abmart Inc cd81 primary antibody
    Characterization of UCMSCs and UCMSC-EVs. ( A ) Phase-contrast image of UCMSCs cultured on the plastic culture plate. Scale bar: 100 μm. ( B ) Representative histograms showing the expression of CD105, CD90, CD73, CD45, CD34, and HLA-DR on the surface of UCMSCs. Unstained cells were included as negative controls to validate the specificity of antibody staining. ( C ) Flow cytometry analysis to quantify the percentage of UCMSC-EVs positive for CD9, CD63, and <t>CD81.</t> ( D ) Western blot analysis of the protein expressions of CD63, CD81, and α-tubulin in UCMSCs and UCMSC-EVs. ( E ) Morphology of UCMSC-EVs (arrowhead), as observed using TEM.
    Cd81 Primary Antibody, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd81+primary+antibody/pm40616949-107-20-26?v=Abmart+Inc
    Average 90 stars, based on 1 article reviews
    cd81 primary antibody - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Preparation of mouse BMSCs and their exosomes. (A) Morphological observation of mouse BMSCs at 120× magnification. To ensure objectivity, five random fields were selected for observation in each analysis. (B) Flow cytometry analysis of the expression of surface markers CD105, CD90, CD73 and CD34 in passage 2 BMSCs. (C) SEM characterization of BMSCs‐Exos. (D) Particle size analysis of BMSCs‐Exos using NTA. (E) Western blot analysis of CD9, CD63, and CD81 protein expression in BMSCs‐Exos, with lysis buffer used as a negative control. Three biological replicates were performed for the experiment ( n = 3), and each replicate was tested three times.

    Journal: The FASEB Journal

    Article Title: Bone Marrow Mesenchymal Stem Cell‐Derived Exosomes Promote M2 Polarization and Protect Against Acute Lung Injury

    doi: 10.1096/fj.202502772R

    Figure Lengend Snippet: Preparation of mouse BMSCs and their exosomes. (A) Morphological observation of mouse BMSCs at 120× magnification. To ensure objectivity, five random fields were selected for observation in each analysis. (B) Flow cytometry analysis of the expression of surface markers CD105, CD90, CD73 and CD34 in passage 2 BMSCs. (C) SEM characterization of BMSCs‐Exos. (D) Particle size analysis of BMSCs‐Exos using NTA. (E) Western blot analysis of CD9, CD63, and CD81 protein expression in BMSCs‐Exos, with lysis buffer used as a negative control. Three biological replicates were performed for the experiment ( n = 3), and each replicate was tested three times.

    Article Snippet: Rabbit anti‐mouse CD9, CD63, and CD81 primary antibodies (ab223052/ab216130, Abcam; 10 037, CST, MA, USA) were diluted at 1:400, 1:400, and 1:600, respectively.

    Techniques: Flow Cytometry, Expressing, Particle Size Analysis, Western Blot, Lysis, Negative Control

    Differential analysis of CD8 + T cells between untreated and GCP-treated ICC samples. (A) UMAP plots showing all T cells labeled in different colors according to cell type annotation. (B) Volcano plot showing the differentially expressed genes of intra-tumoral CD8 + T cells between pretreated and posttreated ICC samples. (C) Immunofluorescence images showing the infiltration of CD8 + CD81 + T cells in treatment-naïve ICC samples from the TMA cohort (n=89). Kaplan–Meier survival curves for OS (D) and RFS (E) of 89 ICC patients grouped by infiltration levels of CD8 + CD81 + T cells. P values were determined via log-rank test. (F) Boxplot showing infiltration levels of CD8 + CD81 + T cells in GCP-treated tumors revealed by multiplex immunofluorescence in GCP cohort. (G) Violin plots showing the expression scores of tissue resident, exhausted, and co-stimulatory gene signatures in tumor-infiltrating CD8 + T cells between pretreated and posttreated samples. The P values were calculated by Wilcox test. OS, overall survival; RFS, recurrence-free survival. ****p < 0.0001.

    Journal: Frontiers in Immunology

    Article Title: Gemcitabine-cisplatin chemotherapy plus anti-PD-L1 therapy reinvigorates antitumor immune response by reprogramming the intrahepatic cholangiocarcinoma microenvironment

    doi: 10.3389/fimmu.2025.1666393

    Figure Lengend Snippet: Differential analysis of CD8 + T cells between untreated and GCP-treated ICC samples. (A) UMAP plots showing all T cells labeled in different colors according to cell type annotation. (B) Volcano plot showing the differentially expressed genes of intra-tumoral CD8 + T cells between pretreated and posttreated ICC samples. (C) Immunofluorescence images showing the infiltration of CD8 + CD81 + T cells in treatment-naïve ICC samples from the TMA cohort (n=89). Kaplan–Meier survival curves for OS (D) and RFS (E) of 89 ICC patients grouped by infiltration levels of CD8 + CD81 + T cells. P values were determined via log-rank test. (F) Boxplot showing infiltration levels of CD8 + CD81 + T cells in GCP-treated tumors revealed by multiplex immunofluorescence in GCP cohort. (G) Violin plots showing the expression scores of tissue resident, exhausted, and co-stimulatory gene signatures in tumor-infiltrating CD8 + T cells between pretreated and posttreated samples. The P values were calculated by Wilcox test. OS, overall survival; RFS, recurrence-free survival. ****p < 0.0001.

    Article Snippet: After that, the slides were incubated with CD81 primary antibody (1:200 dilution, A01281-2, BOSTER) and Alexa Fluor 488 donkey anti-rabbit antibody as described above.

    Techniques: Labeling, Immunofluorescence, Multiplex Assay, Expressing

    Characterization of UCMSCs and UCMSC-EVs. ( A ) Phase-contrast image of UCMSCs cultured on the plastic culture plate. Scale bar: 100 μm. ( B ) Representative histograms showing the expression of CD105, CD90, CD73, CD45, CD34, and HLA-DR on the surface of UCMSCs. Unstained cells were included as negative controls to validate the specificity of antibody staining. ( C ) Flow cytometry analysis to quantify the percentage of UCMSC-EVs positive for CD9, CD63, and CD81. ( D ) Western blot analysis of the protein expressions of CD63, CD81, and α-tubulin in UCMSCs and UCMSC-EVs. ( E ) Morphology of UCMSC-EVs (arrowhead), as observed using TEM.

    Journal: International Journal of Molecular Sciences

    Article Title: Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Enhance Chondrocyte Function by Reducing Oxidative Stress in Chondrocytes

    doi: 10.3390/ijms26167683

    Figure Lengend Snippet: Characterization of UCMSCs and UCMSC-EVs. ( A ) Phase-contrast image of UCMSCs cultured on the plastic culture plate. Scale bar: 100 μm. ( B ) Representative histograms showing the expression of CD105, CD90, CD73, CD45, CD34, and HLA-DR on the surface of UCMSCs. Unstained cells were included as negative controls to validate the specificity of antibody staining. ( C ) Flow cytometry analysis to quantify the percentage of UCMSC-EVs positive for CD9, CD63, and CD81. ( D ) Western blot analysis of the protein expressions of CD63, CD81, and α-tubulin in UCMSCs and UCMSC-EVs. ( E ) Morphology of UCMSC-EVs (arrowhead), as observed using TEM.

    Article Snippet: Overnight incubation at 4 °C was conducted using primary antibodies against CD81 (Proteintech, Rosemont, IL, USA, 66866-1-lg; 1:1000), CD63, and α-tubulin.

    Techniques: Cell Culture, Expressing, Staining, Flow Cytometry, Western Blot